Melanoma Research News: Year in Review

After several years of exciting developments in melanoma therapy, progress continued throughout 2014.

Doctors specializing in the treatment of melanoma reported continued progress about optimizing the use of BRAF inhibitors and the long awaited PD-1 immunotherapy drugs became available for the management of patients with advanced disease.

CancerConnect News coverage of advances in the management of melanoma included the following key developments:

2014 FDA News in Melanoma:

2014 Immunotherapy News:

2014 BRAF/MEK Inhibitor News

2014 Ocular Melanoma News:

2014 Intralesional Therapy for Melanoma:

2014 Screening and Prevention News:

2014 Advocacy News

Current Melanoma News

LEARNING MORE ABOUT MELANOMA

Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey?

  • Sign up for monthly newsletters on melanoma here.
  • Get the facts about melanoma here.
  • Join ongoing discussions with other individuals affected by melanoma in the CancerConnect private online support group here.
  • Follow CancerConnect on Facebook and Twitter.

Copyright © 2018 CancerConnect. All Rights Reserved.

Comments